Insider Trading Activity For Eli Lilly and Company (NYSE:LLY)
Lilly Endowment Inc , Major Shareholder of Eli Lilly and Company (NYSE:LLY) reportedly Sold 180,000 shares of the company’s stock at an average price of 80.85 for a total transaction amount of $14,553,000.00 SEC Form
Insider Trading History For Eli Lilly and Company (NYSE:LLY)
On 3/26/2013 Susan Mahony, SVP, sold 5,000 with an average share price of $56.00 per share and the total transaction amounting to $280,000.00.
On 5/10/2013 Jeffrey N Simmons, SVP, sold 10,000 with an average share price of $54.49 per share and the total transaction amounting to $544,900.00.
On 5/15/2013 Enrique A Conterno, VP, sold 5,000 with an average share price of $56.15 per share and the total transaction amounting to $280,750.00.
On 6/17/2013 Enrique A Conterno, VP, sold 5,000 with an average share price of $52.45 per share and the total transaction amounting to $262,250.00.
On 7/15/2013 Enrique A Conterno, VP, sold 5,000 with an average share price of $51.43 per share and the total transaction amounting to $257,150.00.
On 7/29/2013 Jacques Tapiero, SVP, sold 7,500 with an average share price of $53.74 per share and the total transaction amounting to $403,050.00.
On 8/15/2013 Enrique Conterno, VP, sold 5,000 with an average share price of $53.79 per share and the total transaction amounting to $268,950.00.
Analyst Ratings History For Eli Lilly and Company (NYSE:LLY)
- On 6/15/2016 SunTrust Banks Reiterated Rating Buy
- On 10/27/2016 Societe Generale Reiterated Rating Hold with a price target of $78.00
- On 11/25/2016 Atlantic Securities Downgraded rating Overweight to Neutral
- On 5/21/2017 Sanford C. Bernstein Reiterated Rating Outperform with a price target of $88.00
- On 7/4/2017 Citigroup Reiterated Rating Buy with a price target of $100.00
- On 7/17/2017 Deutsche Bank Reiterated Rating Buy with a price target of $90.00 to $91.00
- On 7/26/2017 Oppenheimer Downgraded rating Outperform to Market Perform with a price target of $90.00 to $90.00
Dividend Information For Eli Lilly and Company (NYSE:LLY)
Eli Lilly and Company (NYSE:LLY) pays an annual dividend of $2.25 with a yield of 2.72% and an average dividend growth of 2.00% (3 Year Average).
Dividend History For Eli Lilly and Company (NYSE:LLY)
On 12/17/2012 Eli Lilly and Company announced a quarterly dividend of $0.49 3.96% with an ex dividend date of 2/13/2013 which will be payable on 3/8/2013.
On 5/6/2013 Eli Lilly and Company announced a quarterly dividend of $0.49 3.62% with an ex dividend date of 5/14/2013 which will be payable on 6/10/2013.
On 6/18/2013 Eli Lilly and Company announced a quarterly dividend of $0.49 3.82% with an ex dividend date of 8/13/2013 which will be payable on 9/10/2013.
On 10/21/2013 Eli Lilly and Company announced a quarterly dividend of $0.49 3.91% with an ex dividend date of 11/13/2013 which will be payable on 12/10/2013.
On 12/16/2013 Eli Lilly and Company announced a quarterly dividend of $0.49 3.98% with an ex dividend date of 2/12/2014 which will be payable on 3/10/2014.
On 5/5/2014 Eli Lilly and Company announced a quarterly dividend of $0.49 3.35% with an ex dividend date of 5/13/2014 which will be payable on 6/10/2014.
On 6/16/2014 Eli Lilly and Company announced a quarterly dividend of $0.49 3.31% with an ex dividend date of 8/13/2014 which will be payable on 9/10/2014.
Recent Trading Activity for Eli Lilly and Company (NYSE:LLY)
Shares of Eli Lilly and Company closed the previous trading session at 82.57 up +1.36 1.67% with 82.72000122070312 shares trading hands.